TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical”...
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 21...
- Expected to enhance visibility and access to U.S. investors - Trading to commence on March 6, 2025 TORONTO...
– IVUS and OCT cited as playing essential and complementary roles, validating Novasight’s unique hybrid imaging...
– Completed first quarter as a public company and raised $10.6 mil CAD concurrent with listing...
TORONTO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Corporation”...
NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES TORONTO...
- U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch...
TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or...
TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the...
– Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved...
– Marks first time as a public company that Conavi is presenting at an investor event – – Live webcast...
– Approval triggers fourth and final US$5.9 million milestone payment to Conavi Medical, which it will use to...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads